PC
BIIB icon

Polar Capital’s Biogen BIIB Stock Holding History

Polar Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$15.8M – 287
2020
Q1 		$15.8M Buy
+50,000
New +$15.2M 0.17% 143
2019
Q3 		– Sell
-50,000
Closed -$11.7M – 285
2019
Q2 		$11.7M Buy
+50,000
New +$11.5M 0.1% 178
2019
Q1 		– Sell
-50,000
Closed -$15M – 271
2018
Q4 		$15M Sell
50,000
-25,000
-33% -$7.98M 0.16% 151
2018
Q3 		$26.5M Hold
75,000
– – 0.23% 130
2018
Q2 		$21.8K Sell
75,000
-15,000
-17% -$4.22M 0.13% 147
2018
Q1 		$24.6M Sell
90,000
-33,413
-27% -$10.4M 0.25% 126
2017
Q4 		$39.3M Buy
123,413
+75,913
+160% +$24.4M 0.41% 81
2017
Q3 		$14.9M Buy
47,500
+17,500
+58% +$5.18M 0.17% 144
2017
Q2 		$8.14M Buy
30,000
+7,000
+30% +$1.85M 0.11% 161
2017
Q1 		$6.29M Hold
23,000
– – 0.09% 167
2016
Q4 		$6.52M Buy
23,000
+7,750
+51% +$2.3M 0.1% 176
2016
Q3 		$4.77M Sell
15,250
-4,016
-21% -$1.19M 0.08% 184
2016
Q2 		$4.66M Buy
19,266
+3,660
+23% +$965K 0.09% 183
2016
Q1 		$4.06M Sell
15,606
-3,052
-16% -$806K 0.08% 184
2015
Q4 		$5.72M Buy
18,658
+9,205
+97% +$2.65M 0.1% 168
2015
Q3 		$2.76M Buy
9,453
+2,022
+27% +$668K 0.06% 206
2015
Q2 		$3M Sell
7,431
-83,352
-92% -$33.5M 0.06% 208
2015
Q1 		$38.3M Buy
90,783
+3,446
+4% +$1.36M 0.72% 42
2014
Q4 		$29.6M Buy
87,337
+10,451
+14% +$3.38M 0.58% 49
2014
Q3 		$25.4M Buy
76,886
+75,180
+4,407% +$24.8M 0.53% 55
2014
Q2 		$538K Sell
1,706
-286
-14% -$86.1K 0.01% 248
2014
Q1 		$609K Buy
1,992
+639
+47% +$203K 0.01% 244
2013
Q4 		$379K Buy
+1,353
New +$350K 0.01% 252

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polar Capital's BIIB Position: Q2 2020 in Review

Polar Capital sold out of Biogen (BIIB) in Q2 2020, closing a stake of 50,000 shares — an estimated $15.8M sold.

Polar Capital first reported a position in BIIB in Q4 2013 and held it in 23 quarters. The position peaked at $39.3M in Q4 2017. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Polar Capital reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Polar Capital sold 50,000 Biogen shares in Q2 2020, an estimated $15.8M.
  • Polar Capital first reported a position in Biogen in Q4 2013 and held it in 23 quarters.
  • Polar Capital's Biogen position peaked at $39.3M in Q4 2017.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.